Cirrhotic cardiomyopathy: the liver affects the heart

Area of Science:

• Cardiology
• Hepatology
• Internal Medicine

Background:

• Cirrhotic cardiomyopathy (CC) is often misdiagnosed as alcoholic cardiomyopathy.
• Historically neglected, CC diagnosis is now vital due to its impact on cirrhotic patient morbidity and mortality.

Purpose of the Study:

• To elucidate the diagnostic criteria and pathogenesis of cirrhotic cardiomyopathy.
• To highlight the clinical significance and management strategies for CC.

Main Methods:

• Review of clinical characteristics, including hyperdynamic circulation, diastolic dysfunction, and impaired contractility.
• Analysis of electrophysiological abnormalities, particularly QT interval prolongation.
• Exploration of pathogenetic mechanisms involving beta-receptors, transmembrane currents, and cardiodepressant factors.
• Diagnostic approaches including serum markers, electrocardiography, echocardiography, and magnetic resonance imaging.

Main Results:

• CC is characterized by a hyperdynamic circulatory state, diastolic relaxation abnormalities, and impaired contractility.
• Electrophysiological abnormalities, notably QT interval prolongation, are common.
• Pathogenesis involves beta-receptor dysfunction, altered ion channel activity, and overproduction of factors like nitric oxide and cytokines.
• Diagnosis relies on clinical signs, cardiac imaging, and biomarkers.

Conclusions:

• Cirrhotic cardiomyopathy is a distinct entity with significant clinical implications in liver cirrhosis.
• While supportive care is primary, orthotopic liver transplantation may offer improvement, though its long-term prognosis in CC patients remains uncertain.